BioM's articles and press releases about the Bavarian biotechnology sector

BioFIT 2024 - get the BioM discount

We offer our net­work 20% dis­count for BioFIT 2023 - Decem­ber 3rd and 4th, 2024 | In-per­son, Lille (France) and Decem­ber 11th & 12th,…

BARDA VITAL Prize (BVP) Challenge: BARDA VITAL Global Health Security Symposium in Berlin

VITAL is on the hunt for break­through vac­cines and thera­peut­ics plat­forms and en­abling tech­no­lo­gies, and it is call­ing on bi­otech…

Eisbach Bio announces FDA clearance of IND application for EIS-12656, a first-in-class allosteric inhibitor of ALC1

Eis­bach Bio GmbH, a privately-held clin­ic­al-stage bi­o­tech­no­logy com­pany in Martin­sried pi­on­eer­ing can­cer medi­cines lever­aging…

PELOBIOTECH GmbH announces collaboration with HVD Life Science Vertriebs GmbH to bring revolutionary Poietis’ Next-Gen Bioprinter to Germany

Bi­o­tech­no­logy com­pany Pelo­bi­otech GmbH from Planegg/Martin­sried, an­nounces a stra­tegic part­ner­ship with HVD Life Science…

m4 Award winner Tubulis on the road to success: 128 million euros in Series B2 funding for the fight against solid tumors

The Mu­nich Bi­otech-Star­tup and m4 Award win­ner Tubulis, loc­ated in Planegg/Martin­sried closes an up­sized EUR 128 mil­lion Ser­ies B2…

BIO-Europe 2024: Outstanding Offer at the German Pavilion– Secure Your Spot Now!

This fall, BIO-Europe re­turns for an en­rich­ing face-to-face ex­per­i­ence, and we're thrilled to be part of it! Join BioM from 4 - 6…

ITOC in Munich: 10th Immunotherapy of Cancer Conference

The Im­mun­o­ther­apy of Can­cer Con­fer­ence (ITOC) is a European meet­ing provid­ing a glob­al plat­form for trans­la­tion­al re­search in…

FGK Clinical Research GmbH Acquires Clinicology Ltd., Expanding Territorial Footprint in Europe

FGK Clin­ic­al Re­search GmbH, a European-based full-ser­vice pro­vider of clin­ic­al re­search ser­vices, is thrilled to an­nounce the…

Start-ups Seeking Capital Founders pitch to investors at BioM BioAngels Pitch Day

Eight pre-se­lec­ted start-ups from medi­cine and life sci­ences pitched their busi­ness ideas at the 13th BioAn­gels Pitch Day hos­ted by…





Julius-Maximilians-Universität Würzburg

Vit­am­in B6: Neuer Wirk­stoff verzögert den Abbau


vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Forschungsin­vesti­tion­en sich­ern Deutsch­lands Wirtschaft im in­ter­na­tionalen Wettbe­w­erb

Publish press release

 To the login

Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead

Christiane Proll
Christiane Proll

PR & Social Media Manager